无菌油管焊机市场 - 增长、趋势、COVID-19 影响和预测(2022 - 2027 年)

无菌管焊机市场按模式(自动、手动)、应用(血液处理、生物制药、诊断实验室)和地理划分。

市场快照

sterile tubing welder market
Study Period: 2018 - 2026
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 4 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

市场概况

预计在预测期内,无菌管焊机市场的复合年增长率为 4%。这归因于研发支出的增加,医院和研究诊所的需求不断增长。此外,一次性技术的日益普及以及对血液和血液制品的需求不断增加,也推动了市场的收入增长。由于这些无菌管道是焊工的重要过程,因为无菌转移在血液处理、生物制药等各个领域发挥着重要作用,从而推动了市场。根据美国国立卫生研究院 (NIH) 发布的一份报告,估计全球有 8500 万单位输血(输血)。这些被输血用于治疗血液疾病,如贫血、白血病、镰状细胞病。如此大量的输血导致血液产品的高需求和采用,从而促进了整个市场的增长。此外,血液污染导致浪费、储存不当、缺乏与血液处理相关的适当处理是推动自动化无菌管焊接机需求并进一步推动市场的一些因素。

报告范围

根据范围,无菌管焊机用于诊断实验室和临床环境中,以形成无菌管连接,在其中它允许无菌转移并将其用于生产各种生物制药药物。无菌油管焊机市场按模式、应用和地理划分。

By Mode
Automatic
Manual
By Applications
Blood Processing
Biopharmaceuticals
Diagnostic Laboratories
Others
By End Users
Hospitals
Research Clinics
Others
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

主要市场趋势

预计血液处理中的无菌管焊机将见证未来的健康发展。

据估计,由于对个性化药物的高需求、血液疾病患病率的增加、对血液和血液制品的需求增加以及细胞和基因治疗的增加,血液处理中的无菌管焊机在未来将出现健康增长。根据世界血友病联合会的数据,2018 年约有 210,454 人经历过血友病,导致对无菌管焊机市场的需求增加。

Sterile Tubing Welder Market

北美预计将在市场上占有重要份额,预计在预测期内也将如此

由于对卫生和无菌环境的需求不断增加、慢性病患病率上升、技术进步、医疗保健支出以及完善的医疗保健基础设施的存在,预计北美将在全球无菌管焊机市场占据重要市场份额。根据美国红十字会的估计,每天需要 36000 个单位的红细胞,美国每年输血约 2100 万份血液成分。从而激增了美国对输血的需求,促进了该地区无菌管市场的增长。

Sterile Tubing Welder Market

竞争格局

无菌管焊机市场竞争中等,由几个主要参与者组成。目前主导市场的一些公司是 Cytiva (GE Healthcare)、TERUMO BCT, INC.、Genesis BPS、MGA Technologies、SARTORIUS AG、Entegris, Inc.、BIOMEN BIOSYSTEMS COMPANY LIMITED 和 Vante Biopharm / Sebra。

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing R&D Expenditure

      2. 4.2.2 Growing Demand across Hospitals and Research Clinics

    3. 4.3 Market Restraints

      1. 4.3.1 Presence of Alternatives

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Mode

      1. 5.1.1 Automatic

      2. 5.1.2 Manual

    2. 5.2 By Applications

      1. 5.2.1 Blood Processing

      2. 5.2.2 Biopharmaceuticals

      3. 5.2.3 Diagnostic Laboratories

      4. 5.2.4 Others

    3. 5.3 By End Users

      1. 5.3.1 Hospitals

      2. 5.3.2 Research Clinics

      3. 5.3.3 Others

    4. 5.4 Geography

      1. 5.4.1 North America

        1. 5.4.1.1 United States

        2. 5.4.1.2 Canada

        3. 5.4.1.3 Mexico

      2. 5.4.2 Europe

        1. 5.4.2.1 Germany

        2. 5.4.2.2 United Kingdom

        3. 5.4.2.3 France

        4. 5.4.2.4 Italy

        5. 5.4.2.5 Spain

        6. 5.4.2.6 Rest of Europe

      3. 5.4.3 Asia-Pacific

        1. 5.4.3.1 China

        2. 5.4.3.2 Japan

        3. 5.4.3.3 India

        4. 5.4.3.4 Australia

        5. 5.4.3.5 South Korea

        6. 5.4.3.6 Rest of Asia-Pacific

      4. 5.4.4 Middle-East and Africa

        1. 5.4.4.1 GCC

        2. 5.4.4.2 South Africa

        3. 5.4.4.3 Rest of Middle-East and Africa

      5. 5.4.5 South America

        1. 5.4.5.1 Brazil

        2. 5.4.5.2 Argentina

        3. 5.4.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Cytiva (GE Healthcare)

      2. 6.1.2 TERUMO BCT, INC.

      3. 6.1.3 Genesis BPS

      4. 6.1.4 MGA Technologies

      5. 6.1.5 SARTORIUS AG

      6. 6.1.6 Entegris, Inc.

      7. 6.1.7 BIOMEN BIOSYSTEMS COMPANY LIMITED

      8. 6.1.8 Vante Biopharm / Sebra

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Sterile Tubing Welder Market market is studied from 2018 - 2026.

The Sterile Tubing Welder Market is growing at a CAGR of 4% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2021.

Cytiva (GE Healthcare), TERUMO BCT, INC., Genesis BPS, MGA Technologies, SARTORIUS AG are the major companies operating in Sterile Tubing Welder Market .

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!